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Defects in actin-cap formation in Vav-deficient mice implicate an
actin requirement for lymphocyte signal transduction
L.J. Holsinger*, I.A. Graef*, W. Swat†, T. Chi*, D.M. Bautista‡, L. Davidson†,
R.S. Lewis‡, F.W. Alt† and G.R. Crabtree*
Background: Antigen-receptor interactions on lymphocytes result in local
clustering of actin, receptors and signaling molecules into an asymmetric
membrane structure termed a cap. Although actin polymerization is known to be
required, the mechanisms underlying cap formation are unclear. We have
studied the events underlying cap formation using mice bearing a null mutation
in vav (vav–/–), a gene that encodes a guanine-nucleotide exchange factor for
the GTPase Rac.
Results: Lymphocytes from vav–/– mice failed to form T-cell receptor caps
following activation and had a defective actin cytoskeleton. The vav–/– T cells
were deficient in interleukin-2 (IL-2) production and proliferation, and the peak
of Ca2+ mobilization was reduced although of normal duration. Activation of Jun
N-terminal kinase or stress-activated kinase (JNK or SAPK) and mitogen-
activated protein kinase (MAPK) and the induction of the transcription factor
NF-ATc1 and egr-1 genes was normal. Despite the reduced Ca2+ mobilization,
translocation of cytoplasmic NF-ATc to the nucleus was normal, reflecting that
the lower levels of Ca2+ in vav–/– cells were still sufficient to activate calcineurin.
Treatment of lymphocytes with cytochalasin D, which blocks actin
polymerization, inhibited cap formation and produced defects in signaling and
IL-2 transcriptional induction in response to antigen-receptor signaling that
were nearly identical to those seen in vav–/– cells. In transfection studies, either
constitutively active Vav or Rac could complement constitutively active
calcineurin to activate NF-AT-dependent transcription.
Conclusions: These results indicate that Vav is required for cap formation in
lymphocytes. Furthermore, the correlation between cap formation, IL-2
production and proliferation supports the hypothesis that an actin-dependent
pathway is a source of specialized growth regulatory signals.
Background
The proto-oncogene vav encodes a member of the family of
guanine-nucleotide exchange factors (GEFs) for the Rho
GTPases and is expressed specifically in hematopoetic cells
[1]. Vav is rapidly tyrosine phosphorylated following the
activation of a variety of growth-factor receptors [2]. Lym-
phocytes from chimeric mice bearing null mutations in both
the vav and rag2 genes (vav–\– rag2–\–) demonstrate a severe
defect in proliferation and interleukin-2 (IL-2) production
mediated by both B and T lymphocyte antigen-receptor sig-
naling, indicating that Vav plays an essential role in antigen-
receptor signal transduction [3–5]. Proliferation of vav–\–
lymphocytes upon exposure to calcium ionophore and
phorbol ester — compounds that act downstream of mem-
brane proximal events — is normal, however, indicating a
receptor-proximal role for Vav. Furthermore, transient trans-
fection studies have demonstrated that Vav may be impor-
tant in T-cell receptor (TCR)-activated signal transduction
pathways that result in NF-AT-dependent transcription and
IL-2 promoter activation [6–8]. Vav was shown recently to
exhibit Rac-specific exchange activity, which is regulated by
tyrosine phosphorylation [9]. The Rac GTPase controls fea-
tures of cell morphology: in fibroblasts its role includes the
stimulation of actin polymerization, the formation of lamel-
lipodia and membrane ruffles, and the assembly of focal
complexes [10–12]. Rho family GTPases appear to control
actin polymerization by binding and activating phospho-
inositol-4-phosphate-5-kinase leading to the production of
phosphotidylinositol-4,5-bisphosphate (PIP2), which regu-
lates actin polymerization and is the precursor of inositol-
1,4,5-trisphosphate (IP3) [13–15], an essential regulator of
intracellular Ca2+ levels. 
Although alleles of Rac have been described that modulate
Jun N-terminal kinase or stress-activated kinase (JNK or
SAPK) activity [16,17], the pathways used by Rac to regu-
late actin polymerization and proliferation appear to be dis-
tinct from those pathways used by Rac to control JNK
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activity [18,19]. Consistent with Vav having a role as a Rac
GEF, Vav overexpression results in the activation of JNK
as well as actin polymerization in fibroblasts [20,21]. Fur-
thermore, Vav-transformed cells have a cellular architecture
and actin morphology similar to that of cells transformed by
another Rho-family GEF, Dbl [22]. Although performed in
fibroblasts, these results indicate that Vav might play some
role in controlling the cytoskeleton in hematopoetic cells. 
Ligand-induced activation of lymphocytes is accompanied
by the clustering of antigen receptors into an asymmetric
membrane structure referred to as a cap [23,24]. Although
the mechanism of cap formation is unknown, it is thought
to involve actin cytoskeletal rearrangements [24,25]. The
function of the cap is unclear; it has been speculated to be
involved either in receptor recycling [26] or perhaps in
signal transduction directly [27]. As TCR cap formation
can be first detected 3 minutes after receptor activation,
whereas tyrosine phosphorylation can be detected as early
as 5 seconds after receptor activation [28], the cap cannot
be essential for early tyrosine phosphorylation. Thus, the
functional significance of the cap remains uncertain. 
Although studies of mice with deletions of the vav gene
indicate that Vav is essential for TCR activation and the
initiation of IL-2 transcription, the signaling pathways that
are dependent on Vav function have not yet been defined.
To study the role of Vav in lymphocyte activation, we
have analyzed TCR signaling pathways in Vav-deficient
lymphocytes and in lymphocytes in which actin-depen-
dent signaling is blocked. Our studies demonstrate that
actin polymerization and subsequent lymphocyte cap for-
mation require Vav activity. Furthermore, our results
suggest a direct role of actin-dependent events in the
propagation of signals to the nucleus. 
Results
Actin cytoskeletal changes and receptor capping are
defective in Vav-deficient lymphocytes
To determine whether Vav is necessary to control the
cytoskeleton in response to TCR signaling, we examined
whether vav–/– T cells had altered actin morphology fol-
lowing antigen-receptor signaling. Following anti-CD3
antibody cross-linking, a new cluster or ‘patch’ of actin
was visualized by phalloidin staining in mature T lympho-
cytes (Figure 1a). This activation-dependent change in F-
actin morphology was virtually absent from vav–/– T cells
following stimulation (Figure 1a). These data demonstrate
directly that Vav is necessary for actin polymerization and
for the regulation of cytoskeletal structures in lympho-
cytes in response to TCR engagement. 
Although the mechanism of cap formation by the TCR
CD3 complex and the function of the cap are unknown,
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Figure 1
F-actin staining and CD3 receptor cap
formation is deficient in vav–/– lymphocytes.
(a) Wild-type and vav–/– T cells were purified
as described in Materials and methods,
stimulated on plates coated with anti-CD3
antibody for 30 min and cytospun on slides.
Cells were fixed, F-actin was visualized by
staining with Texas-red–phalloidin (indicated
by arrows), and the cells were analyzed by
immunofluorescence microscopy. In the right-
hand panel, an average of 100 cells from
representative fields for each stimulation
condition were quantified and the percentage
of cells exhibiting the actin patch is shown.
(b) Wild-type and vav–/– T cells were
stimulated with 1 µg/ml soluble anti-CD3
antibody for 30 min and cytospun on slides.
Cells were fixed and stained as described in
Materials and methods to visualize receptor
caps. In the right-hand panel, the percentage
of cells containing caps is quantified. NS
indicates no stimulation.
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studies have indicated that the cap has a role in clustering
signaling molecules and in proliferation [27,29]. Since
vav–/– T cells exhibited defects in actin morphology fol-
lowing receptor activation, we examined the ability of
these cells to form receptor caps. Wild-type T cells cluster
and cap the CD3 complex following anti-CD3 antibody
stimulation. In contrast, this cap structure is rarely seen
following activation of vav–/– T cells (Figure 1b). These
data demonstrate that cytoskeletal changes directing cap
formation of the CD3 complex are dependent upon Vav.
Initiation of signal transduction pathways in Vav-deficient
lymphocytes 
Mice with null mutations of vav have reduced numbers of
peripheral T cells, and mature B and T lymphocytes from
these mice exhibit dramatically reduced proliferation in
response to antigen-receptor stimuli [3–5]. These initial
studies did not demonstrate any defects in tyrosine phos-
phorylation of substrates following antigen-receptor signal-
ing, suggesting that Vav acts at a point distal to the initial
events involved in receptor-dependent activation of tyro-
sine kinases. We confirmed these results, not finding any
defects in the extent or duration of tyrosine phosphoryla-
tion of TCRζ, Zap70 or PLCγ (data not shown and Fischer
et al. [30]). An early step in both TCR and B-cell receptor
(BCR) activation and in the induction of early response
genes such as IL-2 is the influx of Ca2+ and activation of
the phosphatase calcineurin, leading to the nuclear translo-
cation of NF-AT transcription factor family members
[31–33]. To determine whether vav–/– cells were capable of
activating calcineurin and translocating NF-AT to the
nucleus in response to antigen-receptor signaling, lymph-
node T cells were purified and the subcellular localization
of three NF-AT family members was analyzed by
immunofluorescence microscopy. Both wild-type and
vav–/– T cells exhibited translocation of NF-ATc1 from the
cytoplasm to the nucleus following anti-CD3 cross-linking
(Figure 2). Similar results were obtained with antibodies to
the other NF-AT family members, NF-ATc2 and NF-
ATc3, in vav–/– T cells stimulated with anti-CD3 antibod-
ies, as well as in B cells stimulated with
anti-immunoglobulin M (IgM; data not shown). Because
previous studies have demonstrated that vav–/– thymocytes
have a defect in the Ca2+ response [34], we investigated
whether vav–/– peripheral T cells show a similar defect.
The vav–/– T cells exhibited a decrease in the maximal
intracellular Ca2+ concentration reached after CD3 cross-
linking (Figure 3a). The duration of this peak was identical
to wild-type cells, however. To determine quantitatively
whether the decreased Ca2+ response is sufficient to inter-
fere with NF-ATc translocation, we prepared nuclear
extracts from wild-type and vav–/– cells. The DNA–NF-
AT complexes from extracts of wild-type cells were similar
to the complexes from vav–/– cells indicating that the Ca2+
concentration reached in the vav–/– cells is sufficient to
localize most of the NF-ATc to the nucleus (Figure 3c).
These data confirm the normal translocation of NF-ATc
that was shown in Figure 2. Furthermore, NF-ATc protein
levels were induced normally in vav–/– T cells (Figure 3b).
These data indicate that the reduction in the increase in
intracellular Ca2+ concentration is not sufficient to interfere
with the nuclear translocation of NF-ATc, but could affect
other Ca2+-dependent processes. 
Induction of Ras signaling and activation of the mitogen-
activated protein kinase (MAPK) cascade, culminating in
p42 extracellular signal-regulated kinase (ERK) activa-
tion, are early signaling events in both T and B lympho-
cytes [35–37]. As B-lymphocyte activation and
proliferation is also defective in vav–/– B cells, which are
sufficiently abundant in vav–/– mice for biochemical analy-
sis, we investigated the activation of other signaling path-
ways in B cells. The levels of ERK and JNK activation in
vav–/– B cells from vav–/– rag2–/– chimeric mice were indis-
tinguishable from wild-type B cells (Figure 4a). We noted
that the duration of MAPK activation was very transient
following TCR cross-linking and was similar in vav–/– and
wild-type cells. In the accompanying paper by Fischer et
al. [30], MAPK as well as JNK was activated normally fol-
lowing TCR cross-linking in vav–/– T lymphocytes. These
results are consistent with the existence of Vav-indepen-
dent pathways of ERK and JNK activation in both T and
B lymphocytes. To test more rigorously the MAPK
pathway in T cells we investigated the induction of the
egr-1 gene, which is a target of the MAPK pathway. The
egr-1 gene was induced normally in vav–/– T cells after
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Figure 2
Nuclear translocation of NF-ATc is normal in vav–/– lymphocytes. Wild-
type and vav–/– lymph-node T cells were purified, stimulated as
indicated, and stained with an antibody against NF-ATc1 to visualize
the subcellular localization of NF-AT. 
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anti-CD3 antibody treatment (Figure 4b), consistent with
the observation that MAPK activation is normal in Vav-
deficient lymphocytes. To further examine the ability of
vav–/– T cells to activate MAPK and JNK, we examined
the AP-1 activity in vav–/– T cells. AP-1 requires JNK for
the activation of Jun and requires the MAPK pathway for
the induction/activation of Fos. AP-1 DNA-binding activ-
ity was normal in vav–/– T cells compared to wild-type
cells (Figure 4c). Thus, by three independent criteria, the
JNK and MAPK pathways do not require Vav activity.
Inhibition of actin polymerization disrupts signal
transduction induced by the TCR
The signaling defects in vav–/– lymphocytes could be due
either to a failure of actin polymerization, or to a failure to
activate a Vav-dependent pathway independent of actin
polymerization and the cap. To distinguish these two pos-
sibilities, we examined the effects of cytochalasin D treat-
ment on IL-2 transcription. Freshly isolated human
peripheral blood lymphocytes (PBLs) were stimulated by
antibody cross-linking of CD3 and CD28 for 4 hours in the
presence and absence of cytochalasin D, and properly ini-
tiated transcription of IL-2 was measured by ribonuclease
protection. Transcription of IL-2 was completely blocked
by the presence of 5 µM cytochalasin D (Figure 5a). In
cells stimulated with ionomycin and phorbol 12-myristate
13-acetate (PMA), however, IL-2 transcription was insen-
sitive to cytochalasin D (Figure 5a). This observation indi-
cates that cytochalasin D treatment had no effect on
signaling events distal to Ca2+ mobilization and phorbol
566 Current Biology, Vol 8 No 10
Figure 3
Ca2+ mobilization and NF-AT DNA-binding
activity in vav–/– lymphocytes. (a) Vav-deficient
T lymphocytes have reduced peak Ca2+ levels
without a change in the duration of the peak.
Single-cell Ca2+ mobilization in lymph-node T
cells from wild-type and vav–/– mice was
measured following TCR stimulation induced
by the addition of anti-CD3 antibodies, which
were cross-linked by the addition of goat anti-
hamster antibody (GαH) [49]. Each graph is
the average response of 100–200 cells. (b)
NF-ATc is induced normally in Vav-deficient
lymphocytes. Total cell lysates were prepared
from wild-type and vav–/– lymph-node T cells
following the indicated stimulations and
analyzed by SDS–PAGE; western blots were
probed with an antibody against NF-ATc1. (c)
NF-ATc DNA-binding activity is normal in Vav-
deficient lymphocytes. Nuclear extracts were
prepared from wild-type and vav–/– lymph-
node T cells after the indicated stimulations
and assayed for NF-AT DNA-binding activity.
NS indicates no stimulation, I+P indicates
ionomycin and PMA. 
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ester action. Rather, cytochalasin D blocks a proximal sig-
naling event, which, like the defect in vav–/– lymphocytes,
can be bypassed with ionomycin and PMA. Activation of
transcription dependent on the IL-2 promoter by CD3 and
CD28 receptor cross-linking in the Jurkat T-cell line was
also blocked by cytochalasin D (Figure 5b, upper panel).
To investigate which specific signaling pathways directing
transcription from the IL-2 promoter were affected by
cytochalasin D, we investigated the effect of the drug on
several specific transcriptional targets. As shown in the
lower panel of Figure 5b, activation of NF-AT-dependent
transcription was inhibited by cytochalasin D. 
If Vav promoted signaling by inducing actin polymeriza-
tion, one would predict that cytochalasin D would mimic
the intracellular signaling defects of vav–/– cells. This
appears to be the case: 10 µM cytochalasin D did not
block the initiation of early, well-characterized cytoplas-
mic signaling events following cross-linking of the Jurkat
TCR, such as the activation of tyrosine kinases and the
phosphorylation of their substrates (Figure 6a). In addi-
tion, the activation of MAPK and JNK by TCR cross-
linking was unaffected (Figure 6b), and no effect was seen
on the induction of c-Fos protein (Figure 6c). Thus, the
defects in TCR signaling induced by inhibition of actin
polymerization with cytochalasin D are very similar to
those seen in vav–/– lymphocytes.
NF-AT is a transcriptional target of Vav GEF activity
NF-ATc family members appear to have an inadequate
DNA-binding domain rendering them dependent upon a
nuclear partner protein NF-ATn such as AP-1 for binding
to DNA at physiological protein concentrations [38].
Because of this structural feature, NF-ATc family
members require both a ras–PKC (protein kinase C) and a
Ca2+–calcineurin signal for activation, making them
dependent on two signaling pathways [39]. We used this
characteristic of NF-AT to define the role of Vav in sig-
naling. To identify more precisely a specific transcrip-
tional target of Vav GEF activity, we determined whether
Vav might function through Rac to control NF-AT-
dependent transcription. Consistent with this hypothesis,
a dominant-negative allele of Rac has been reported to
block NF-AT-dependent transcriptional activation [40].
We constructed a deletion mutant of vav encoding only
the GEF domain and the pleckstrin homology (PH)
domain, eliminating all other regions of Vav that might
facilitate regulation and/or interaction with other proteins.
Expression of this truncated mutant, designated VavPC,
did not activate NF-AT-dependent transcription alone
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Figure 4
Activation of the MAPK and JNK pathways is
normal in Vav-deficient lymphocytes.
(a) MAPK and JNK are induced normally in
Vav-deficient lymphocytes. MAPK and JNK
activation were measured from purified
splenic B cells stimulated with ionomycin and
PMA (I+P) or with anti-IgM cross-linking
antibody for the indicated times. Lysates were
analyzed by SDS–PAGE and western blots
probed with anti-ERK or anti-JNK antibodies.
The black arrows indicate the mobility of
phosphorylated p42 ERK or JNK and the grey
arrows indicate the mobility of
nonphosphorylated p42 ERK or JNK.
(b) Egr-1 is induced normally in Vav-deficient
lymphocytes. Total lysates were prepared
from wild-type and vav–/– lymph-node T cells,
analyzed by SDS–PAGE and western blots
probed with anti-Egr-1 antibody. (c) AP-1
DNA-binding activity is normal in Vav-deficient
lymphocytes. Nuclear extracts were prepared
from wild-type and vav–/– lymph-node T cells
after the indicated stimulations and assayed
for AP-1 DNA-binding activity. NS indicates
no stimulation.
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but synergized with a constitutively active allele of cal-
cineurin to activate NF-AT-dependent transcription
(Figure 7a). This is consistent with Vav playing a role in
the phorbol ester or Ras requirement for NF-AT function.
This synergy with calcineurin was also seen with a consti-
tutively active allele of Rac1 and to a lesser extent with
Cdc42, but not with RhoA (Figure 7b). Mutations in con-
served residues of the GEF domain, known to be essen-
tial for the catalytic activity of other Rho-family GEFs,
blocked the activity of VavPC and demonstrate that this
function is dependent on the Rac GEF activity of Vav
(Figure 7a). These data indicate that the GEF activity of
Vav plays a role in TCR signaling, and synergizes with
Ca2+–calcineurin to facilitate NF-AT transcriptional acti-
vation. These data also support previous work indicating
that Vav exerts its actions by activating Rac.
Discussion
These studies demonstrate that the Rac exchange factor
Vav is necessary for the formation of the cap following
antigen-receptor stimulation in T and B lymphocytes.
The requirement for Rac/Cdc42 GTPases for the forma-
tion of lamellipodia and filopodia in fibroblasts in response
to a variety of growth factors is well known. The receptor
cap and actin patch may therefore represent unique struc-
tures formed by Rac and Vav specifically in lymphocytes. 
Although at least one mechanism of capping has been pro-
posed to be the result of the simple aggregation of cross-
linked molecules [41], the failure of vav–/– lymphocytes to
form caps indicates that TCR signaling activates intracellu-
lar targets that facilitate cap formation. In addition, our
studies indicate that the cap-dependent and actin-depen-
dent events are essential components in T-cell signal trans-
duction, rather than a passive result of receptor
cross-linking. Consistent with the actin morphology
observed in vav–/– lymphocytes as well as in cytochalasin-
D-treated lymphocytes, T cells containing mutations in
Wiskott–Aldrich syndrome protein (WASP), which binds
Cdc42 and clusters actin [42,43], are also deficient in IL-2
production [44]. In one study, however, a dominant-nega-
tive allele of Cdc42 was demonstrated to interfere with the
cytoskeletal polarization of T cells toward antigen-present-
ing cells without affecting IL-2 transcription [45]. Thus,
there appear to be at least two roles for the cytoskeleton in
lymphocyte activation: one involved with polarization of
the lymphocyte to antigen-presenting cells, and the other
involved in formation of the cap and in the propagation of
signals to the nucleus. 
As several reports have shown that Rac regulates JNK (or
SAPK) activity, we were surprised to find that JNK activ-
ity appeared normal in vav–/– T and B cells. The data sup-
porting this conclusion in our studies and those of Fischer
et al. [30] are as follows: firstly, JNK activation was normal
in vav–/– B and T cells; secondly, AP-1 electrophoretic
mobility shift assays were normal in vav–/– lymphocytes;
and thirdly, induction of the egr-1 gene was normal. Many
of the known functions of Rho family GTPases have
been derived from studies with constitutively active and
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Figure 5
Cytochalasin D blocks TCR-dependent
activation of IL-2 transcription. (a) Human
PBLs were isolated as described in Materials
and methods and stimulated for 4 h with anti-
CD3 and anti-CD28 antibodies, or with
ionomycin and PMA (I+P), and also in
combination with the indicated concentrations
of cytochalasin D (cyt D). Cells were analyzed
for the presence of IL-2 transcripts by
ribonuclease protection, and the probe-
protected transcripts were quantitated by
phosphorimager analysis. C indicates control
stimulation using tRNA. (b) Cytochalasin D
blocks IL-2-dependent and NF-AT-dependent
transcriptional activation in Jurkat T cells.
Jurkat cells stably expressing SV40 T antigen
were transfected with plasmids containing the
luciferase reporter gene driven by either the
IL-2 promoter (upper panel) or the NF-AT
response element (lower panel). After 24 h,
cells were treated with cytochalasin D,
stimulated with either soluble anti-CD3 and
anti-CD28 antibodies, or plate-bound anti-
CD3 and anti-CD28 antibodies for 5 h, and
lysates analyzed for luciferase activity. NS
indicates no stimulation.
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dominant-negative alleles of these proteins. However,
recent studies have demonstrated that constitutively
active and dominant-negative alleles of Rho family
GTPases acquire functions that may be unrelated to the
normal function of these proteins [46], raising a note of
caution in the use of these mutant alleles of GTPases. We
favor the view that the physiological function of Vav in
lymphocytes is not related to JNK activation but rather to
cytoskeletal regulation and calcium mobilization. 
Our results and those of Fischer et al. [30] are quite similar
but despite several attempts we have not been able to
resolve a minor discrepancy. They observed a decrease in
the level of NF-ATc1 gene induction in vav–/– lympho-
cytes. This difference may be due to strain background or
to the nature of the ‘knockout’ constructs. Despite our
inability to reconcile this minor difference, the observa-
tion that the immunological phenotype is the same in the
two vav–/– mice strongly indicates that this difference is
not related to the defects in IL-2 gene activation.
Although our data indicate that actin polymerization is not
required for the initiation of early receptor signaling events
such as tyrosine kinase, MAPK and JNK activation, it is
possible that the function of actin polymerization and cap
formation may be either to concentrate receptors and sig-
naling molecules in order to reduce the threshold required
for full activation, or to prolong existing signals that are
essential for activation [26]. Sustained Ca2+ mobilization, for
example, is essential for NF-AT nuclear localization and
subsequent IL-2 transcription [47]. Whereas gene transcrip-
tion and proliferation are prolonged responses following
receptor stimulation, the initiation of signaling pathways
measured by phosphotyrosine induction, MAPK activation
and JNK activation are transient events, lasting only
minutes [28]. Although we found a reduction in the peak
intracellular Ca2+ concentration following TCR engage-
ment, analysis of single cell intracellular Ca2+ concentration
changes showed no difference in the duration of Ca2+ mobi-
lization. Therefore, we believe that this result argues
against Vav having an effect on the duration of signaling. 
Clustering and capping of the TCR CD3 complex could
function to amplify an initial low level of signaling by
recruitment of additional receptor complexes and associ-
ated signaling molecules into a stable activated receptor
complex. The recruitment of additional receptors to the
activated complex might allow the T cell to amplify the
signal derived from a low level of specific antigen to the
threshold required to activate transcription of immune-
response genes. Activation of T cells by physiological
ligands also requires serial receptor engagement followed
by receptor turnover [48], which could be influenced by
the actin cytoskeleton. The role of Vav in the regulation of
cytoskeletal organization may also be necessary to coordi-
nate or integrate the network of costimulatory signals,
such as those provided by CD28 and CD4, required for
maximal T-cell proliferation.
Alternatively, Vav and the cap structure may be the
source of an additional specialized signal essential for IL-2
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Figure 6
Antigen-receptor-induced signaling pathways in T cells are unaffected
by cytochalasin D. (a) Induction of tyrosine phosphorylation in Jurkat T
cells was measured after stimulation with anti-CD3 antibodies in the
presence or absence of 5 µM cytochalasin D (cyt D). Lysates were
analyzed by western blotting with an anti-phosphotyrosine antibody
(anti-PTyr). (b) Activation of MAPK and JNK in Jurkat T cells was
measured following stimulation with anti-CD3 or anti-CD3 plus anti-
CD28 antibodies (anti-CD3+28), or ionomycin and PMA (I+P) for
15 min, in the presence or absence of 5 µM cytochalasin D. Lysates
were analyzed by western blot with anti-ERK or anti-JNK antibodies.
The black arrows indicate the mobility of phosphorylated p42 ERK or
JNK and the grey arrows indicate the mobility of the
nonphosphorylated kinases. (c) Transcriptional induction of c-Fos was
measured following anti-CD3 and anti-CD28 antibody stimulation of
Jurkat T cells for the indicated times in the presence and absence of
cytochalasin D. Lysates were analyzed by western blot with an anti-c-
Fos antibody for the induction of c-Fos protein levels. NS indicates no
stimulation.
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transcription and proliferation. This view is supported by
the observation that in vav–/– cells and in cytochalasin-D-
treated cells, the activation of JNK and MAPK, and the
induction of the c-fos and egr-1 genes were normal
whereas IL-2 transcription was not detectable. Thus, a
specific set of early genes require Vav and the actin
cytoskeleton, indicating that Vav is required for specific
signaling pathways but not others. This observation is
supported by the finding of specific alleles of Rac that
activate changes in the cytoskeleton and proliferation but
do not activate  JNK, whereas other alleles of Rac activate
JNKs but have no effect on cell proliferation [18,19].
Thus, distinct signaling pathways appear to regulate JNK
activation and actin polymerization. One interpretation of
our results that we favor is that Vav directs Rac towards the
regulation of actin, Ca2+ levels and proliferation, whereas
some other exchange factor may direct Rac to JNK activa-
tion. At present, our studies show that the changes in sig-
naling induced by inhibiting actin polymerization correlate
very closely with those seen in the vav–/– lymphocytes.
Kupfer and colleagues [27] have pointed out that one can-
didate for a signaling molecule controlled by the actin cap
is PKCθ, which is clustered at T cell–antigen-presenting
cell contact sites. Additional PKC family members, depen-
dent on Ca2+, may also be involved. 
Conclusions
Our results demonstrate that the Rho family GTPase
exchange factor Vav is essential for formation of the actin
cap following antigen-receptor signaling in T lympho-
cytes. Furthermore, our studies identify NF-ATc as a
downstream target for an actin-dependent pathway con-
trolling cell proliferation through the growth factor IL-2
and should allow an effective approach to defining the
steps in this pathway. By regulating actin polymerization
and cap formation during lymphocyte activation, Vav may
bring signaling molecules into close proximity to permit
their activation or affect the duration of signaling, ulti-
mately resulting in the activation of genes involved in pro-
liferation and the immune response.
Materials and methods
The vav–/– rag2–/– chimeric mice and lymphocyte purification
The vav–/– rag2–/– chimeric mice were prepared as described [3] by
injection of vav–/– embryonic stem (ES) cell clones into blastocysts
derived from rag2–/– mice. All mice used were between 8 and
12 weeks of age. B cells from wild-type (129 strain) or age-matched
vav–/– rag–/– chimeric mice were purified from spleen by magnetic
removal of T cells using standard techniques of antibody staining with
FITC-conjugated anti-Thy1.2, anti-CD4, anti-CD8, anti-CD3, anti-Mac-1
or anti-Gr-1 antibodies, followed by incubation with sheep anti-FITC-
coated magnetic beads (Perseptive Diagnostics). T cells were purified
from lymph node by removal of B cells using anti-mouse Ig-coated Dyn-
abeads (Dynal). Purity was confirmed in each preparation by floures-
cence-activated cell sorting (FACS) and exceeded 90% for T cells and
85% for B cells. Lymphocytes were cultured in RPMI 1640 medium
supplemented with 2% fetal calf serum (FCS), 100 U/ml
penicillin–streptomycin, L-glutamine, and 50 µM 2-mercaptoethanol.
Immunofluorescence microscopy
Purified T cells were stimulated at a concentration of 3 × 106 cells/ml in
96-well plates and, where indicated, stimulated for 30–60 min with
10 µg/ml plate-bound anti-CD3ε antibody (2C11, Pharmingen).
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Figure 7
The Vav GEF catalytic domain and RacV12 or Cdc42V12 synergize with
calcinuerin to activate NF-AT-dependent transcription.(a) Jurkat cells
stably expressing the SV40 T antigen were cotransfected with control
plasmid (pBJ5), or with plasmids encoding a truncated version of Vav
containing the GEF domain and the PH domain (amino acids 143–597;
VavPC) or VavPC containing the indicated mutations in the GEF domain
(mut1, mut2, del204; see Materials and methods), together with
constitutively active calcineurin (CN) and an NF-AT–SEAP (secreted
alkaline phosphatase) reporter plasmid. At 24 h post-transfection, cells
were assayed for activity of the reporter gene. Expression of the proteins
was verified by immunoblotting with an antibody against their
hemagglutinin (HA) epitope tags (see inset). (b) Cells were transfected
as in (a), together with CN and the indicated constitutively active mutants
of Rac, Cdc42 or Rho. Expression of all proteins was verified by
immunoblotting with an antibody against their Myc tags (see inset). 
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Soluble anti-CD3 antibody at a concentration of 1 µg/ml was used for
capping studies. Cells were cytospun for 3 min at 500 rpm on poly-L-
lysine-coated slides, fixed and permeabilized in acetone for 15 sec at
–20°C and in methanol for 1.5 min at –20°C followed by a PBS wash.
Cells were stained for actin with Texas-red–phalloidin (Sigma). For
capping studies, following stimulation, cells were stained with anti-
CD3–biotin (1:500, Pharmingen) or anti-hamster–biotin (1:1000,
Jackson Immuno Research) followed by avidin D–FITC (1:1000,
Vector). Cells were stained following a 60 min stimulation for NF-AT
family members as described [47]. 
Kinase assays and phosphotyrosine induction
For analysis of MAPK and JNK activation, splenic B cells were purified
from splenocytes from wild-type and vav–/– rag2–/– chimeric mice and
were stimulated with 20 µg/ml soluble anti-IgM antibody (Southern
Biotechnology Associates) or 1 µM ionomycin (Sigma) and 25 ng/ml
PMA (Sigma) for the indicated times at 37°C. Jurkat T cells were stimu-
lated with soluble anti-CD3 monoclonal antibody (OKT3 ascites,
1:1000) for MAPK activation and OKT3 plus anti-CD28 antibody
(Immunotech, 1 µg/ml) for JNK activation, or ionomycin and PMA for
the indicated times. For Jurkat T-cell activations, where indicated,
cytochalasin D (2–10 µM, Sigma) was preincubated with cells for
30 min prior to stimulation and maintained at this concentration
throughout. Following stimulation, cells were lysed in buffer containing
20 mM Tris pH 6.8, 50 mM NaF, 1% Triton X-100, 1 mM EDTA supple-
mented with protease and phosphatase inhibitors. Lysates were ana-
lyzed by SDS–PAGE under conditions that allowed resolution of the
phosphorylated activated forms of ERK and JNK, and blots were
probed with either anti-ERK monoclonal antibody (Zymed) or anti-JNK
antisera (Santa Cruz Biotechnology). Each lane contains the lysate
from 1 × 106 lymphocytes. For phosphotyrosine induction and analysis
of c-Fos levels, Jurkat T cells were stimulated with anti-CD3 antibody
for the indicated times in the presence and absence of 10 µM cytocha-
lasin D, lysates were analyzed by SDS–PAGE, and western blots
probed with either anti-phosphotyrosine antibody 4G10 (Upstate
Biotechnology) or anti-c-Fos antisera (Santa Cruz Biotechnology).
Preparation of nuclear extracts and electrophoretic mobility shift assays
were performed as described [33]. For NF-ATc1 and Egr-1 induction,
purified lymph-node T cells were stimulated for 16 h with plate bound
anti-CD3 antibody, lysates analyzed by SDS–PAGE , and probed with
either anti-NFATc1 monoclonal antibody (7A6) or anti-Egr-1 antiserum
(Santa Cruz Biotechnology). Measurements of intracellular Ca2+ follow-
ing TCR stimulation on wild-type and vav–/– purified lymph-node T cells
were performed essentially as described [49]. Each graph represents
the average response of 100–200 cells.
Analysis of IL-2 transcription
Freshly isolated human PBLs were obtained from fresh buffy coats
received from the Stanford Blood Bank followed by standard isolation
on Ficoll–Paque (Pharmacia). PBLs were stimulated at 1 × 107 cells/ml
in six-well plates with 100 ng/ml plate-bound anti-CD3 antibody
(OKT3) and 400 ng/ml soluble anti-CD28 antibody, or with ionomycin
and PMA. Cytochalasin D was preincubated with cells for 30 min prior
to stimulation and maintained throughout. RNA was prepared and
RNase protection studies were performed as described [50] using a
riboprobe which protects a 52 bp fragment from IL-2 transcripts. 
Transfections and reporter gene analysis
Jurkat cells stably expressing SV40 T antigen [51] were transfected
by electroporation at 250 V, 960 µF, in 0.4 cm cuvettes with mam-
malian expression constructs all based on the pBJ5 vector. Cells
(1 × 107) were transfected with 2 µg of NF-AT–SEAP reporter
plasmid, 6 µg of VavPC, Rac1V12, RhoAV14, Cdc42V12 or pBJ5
vector control and, where indicated, the constitutively active allele of
calcineurin. Total DNA transfected was equalized by the addition of
pBJ5 vector control. Secreted alkaline phosphatase reporter gene
activity was measured at 24 h after transfection. VavPC was con-
structed by fusing an ATG translational start site with amino acids
143–597 of Vav [1], followed by an hemagglutinin (HA)-epitope tag.
Mutants in conserved amino-acid residues of VavPC were con-
structed by PCR-mediated mutagenesis: for mut1, residues 338–341
LLLQ were changed to AAAA; for mut2, residues 341–344 QELV
were changed to AAAA; in del204 residues 204–217 were deleted.
Full-length expression of all constructs was verified by immunoblotting
lysates with the anti-HA epitope tag antibody 12CA5 for all Vav con-
structs, or with the anti-Myc epitope tag antibody 9E10 (Pharmingen)
for Rac and Rho constructs. For cytochalasin D experiments, a wild-
type Jurkat T-cell line was transfected with 3 µg of NF-AT–luciferase
or IL-2–luciferase reporter plasmid, cells were stimulated for 4 h and
assayed for reporter gene activity. 
Supplementary material
A figure showing that CD3 capping is blocked by cytochalasin D is
published with this paper on the internet.
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S1Supplementary material
Figure S1
Cytochalasin D inhibits CD3 receptor
capping. Wild-type lymph-node T cells were
purified and analyzed for CD3 receptor
capping as described in Figure 1b. Cells were
stimulated for 30 min with soluble anti-CD3
antibody in the presence or absence of 10 µM
cytochalasin D (cyt D) followed by secondary
antibody staining of CD3.
Nonstimulated Anti-CD3 Anti-CD3 + cytD
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